Correlation Between FibroGen and Vertex Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both FibroGen and Vertex Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining FibroGen and Vertex Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between FibroGen and Vertex Pharmaceuticals, you can compare the effects of market volatilities on FibroGen and Vertex Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in FibroGen with a short position of Vertex Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of FibroGen and Vertex Pharmaceuticals.

Diversification Opportunities for FibroGen and Vertex Pharmaceuticals

-0.69
  Correlation Coefficient

Excellent diversification

The 3 months correlation between FibroGen and Vertex is -0.69. Overlapping area represents the amount of risk that can be diversified away by holding FibroGen and Vertex Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vertex Pharmaceuticals and FibroGen is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on FibroGen are associated (or correlated) with Vertex Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vertex Pharmaceuticals has no effect on the direction of FibroGen i.e., FibroGen and Vertex Pharmaceuticals go up and down completely randomly.

Pair Corralation between FibroGen and Vertex Pharmaceuticals

Assuming the 90 days trading horizon FibroGen is expected to under-perform the Vertex Pharmaceuticals. In addition to that, FibroGen is 3.24 times more volatile than Vertex Pharmaceuticals. It trades about -0.12 of its total potential returns per unit of risk. Vertex Pharmaceuticals is currently generating about 0.48 per unit of volatility. If you would invest  814,943  in Vertex Pharmaceuticals on November 9, 2024 and sell it today you would earn a total of  166,062  from holding Vertex Pharmaceuticals or generate 20.38% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

FibroGen  vs.  Vertex Pharmaceuticals

 Performance 
       Timeline  
FibroGen 

Risk-Adjusted Performance

Good

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in FibroGen are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, FibroGen showed solid returns over the last few months and may actually be approaching a breakup point.
Vertex Pharmaceuticals 

Risk-Adjusted Performance

Weak

 
Weak
 
Strong
Over the last 90 days Vertex Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Vertex Pharmaceuticals is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

FibroGen and Vertex Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with FibroGen and Vertex Pharmaceuticals

The main advantage of trading using opposite FibroGen and Vertex Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if FibroGen position performs unexpectedly, Vertex Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vertex Pharmaceuticals will offset losses from the drop in Vertex Pharmaceuticals' long position.
The idea behind FibroGen and Vertex Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..

Other Complementary Tools

Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Commodity Directory
Find actively traded commodities issued by global exchanges
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum